Measles vaccine effectiveness in African children: a systematic review and meta-analysis

Measles vaccine effectiveness in African children: a systematic review and meta-analysis

Abstract Introduction Measles is an extremely contagious viral disease that can be prevented through vaccination. It is caused by the measles virus and presents with symptoms such as high fever, cough, runny nose, conjunctivitis, and a distinctive rash. Complications may include pneumonia, diarrhoea...

Full description

Saved in:

Bibliographic Details
Main Authors:	Demeke Endalamaw, Endalkachew Nibret, Abaineh Munshea, Feleke Mekonnen, Senait Tadesse, Taye Zeru, Mesfine Tefera, Gizachew Yismaw
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	BMC Infectious Diseases
Subjects:	African children Measles vaccine Vaccine effectiveness Vaccine effectiveness systematic review
Online Access:	https://doi.org/10.1186/s12879-024-10239-w
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Cross-sectional Study to Understand the Reasons for Failure to Vaccinate Eligible Children with Measles-containing Vaccine among the Clinically Diagnosed Measles Cases during the Outbreak (2022) in a District of Maharashtra
by: Sudhir V Sane, et al.
Published: (2024-03-01)

Unveiling immunity gaps and determining a suitable age for a third dose of the measles-containing vaccine: a strategic approach to accelerating measles eliminationResearch in context
by: Somya Mehra, et al.
Published: (2025-01-01)

Measles seroprevalence in Thailand: are adolescents and young adults at risk of measles?
by: Panit Takkinsatian, et al.
Published: (2024-06-01)

Measles, mumps and rubella vaccination coverage in capitals and interior region municipalities of Northeast Brazil: a household survey in a cohort of children born in 2017 and 2018
by: Adjoane Mauricio Silva Maciel, et al.
Published: (2024-12-01)

Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of Ethiopia
by: Kalkidan Solomon, et al.
Published: (2024-06-01)

Measles-mumps-rubella vaccination experience in children with egg allergy
by: Öner Özdemir, et al.
Published: (2024-02-01)

Topical issues of vaccination and epidemiological surveillance over measles and rubella in Ukraine.
by: G. M. Daragan, et al.
Published: (2018-04-01)

Securing long-term immunity: The possible necessity of supplementary measles vaccination
by: Furkan Kalayci, et al.
Published: (2024-11-01)

Changes in Hematologic Parameters After Second and Third Doses of Measles Immunization in Children
by: Selçuk Kaya, et al.
Published: (2009-06-01)

Impact of Measles Vaccination Coverage on Disease Severity Among Children Under Five Years of Age in Diyala Province, Iraq
by: Aseel Muhammad, et al.
Published: (2024-12-01)

Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations
by: Darin Zehrung, et al.
Published: (2024-11-01)

Global challenges and solutions to achieving and sustaining measles and rubella elimination
by: Natasha S. Crowcroft, et al.
Published: (2024-12-01)

Sustaining measles and rubella elimination through the Regional Monitoring and Re-Verification Commission in the Americas
by: Jon K. Andrus, et al.
Published: (2024-12-01)

Low IgG Seroconversion among Persons Vaccinated against Measles, Republic of Congo
by: Yanne Vanessa Thiécesse Mavoungou, et al.
Published: (2025-01-01)

Incidence of measles specific IgG antibody among children in Adamawa State, Nigeria
by: Isa, H., et al.
Published: (2019-06-01)

The Health and Economic Benefits of United States Investments in Measles and Rubella Control and Elimination
by: Kimberly M. Thompson
Published: (2024-10-01)

A mathematical model for distributed waning of vaccine-derived immunity: Characterizing dynamical impact on measles elimination
by: Aniruddha Deka, et al.
Published: (2024-12-01)

Spatial analysis of measles cases and vaccination coverage in the Somali region, eastern Ethiopia
by: Abdilahi Ibrahim Muse, et al.
Published: (2025-02-01)

Peran Measles-Containing-Vaccine dalam Pencegahan Coronavirus Disease 2019 (COVID-19)
by: Diandra Tatiana, et al.
Published: (2024-12-01)

Lessons for sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Caribbean
by: Tracy Evans-Gilbert, et al.
Published: (2024-12-01)

Vaccination coverage, delay and loss to follow-up of the triple viral vaccine, in live births between 2017 and 2018 in Brazilian cities
by: Tatiana Lang D’Agostini, et al.
Published: (2024-12-01)

Regional Disparities in Measles Vaccination Coverage and Their Associated Factors: An Ecological Study in Japan
by: Masaki Machida, et al.
Published: (2025-02-01)

Economic evaluation of second measles containing vaccine (MCV) dose: a systematic review of available evidence
by: Samuel Bawa, et al.
Published: (2024-12-01)

Contemporary Treatment Practices for Subacute Sclerosing Panencephalitis: A Nationwide Survey Among Adult and Pediatric Neurologists in India
by: Divyani Garg, et al.
Published: (2024-12-01)

Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US
by: Stephen I. Pelton, et al.
Published: (2024-12-01)

Methicillin-resistant Staphylococcus Aureus Bacteraemia in a Young Boy following Mumps Infection: A Case Report
by: Jayakanthan Saravanan, et al.
Published: (2025-01-01)

Effectiveness of influenza vaccination in preventing confirmed influenza cases and hospitalizations in Northern Spain, 2023/24 season: A population-based test-negative case-control study
by: Iván Martínez-Baz, et al.
Published: (2025-02-01)

Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)
by: Po-Han Huang, et al.
Published: (2025-12-01)

Measles Outbreaks in Afghanistan
by: Abubakr Yosufi, et al.
Published: (2024-03-01)

Contagion comeback: unravelling the measles outbreak across the USA
by: Iman Muhammad Tahir, et al.
Published: (2024-12-01)

Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable
by: Chiara de Waure, et al.
Published: (2024-12-01)

Mapping and ranking outcomes for the evaluation of seasonal influenza vaccine efficacy and effectiveness: a delphi study
by: Chiara de Waure, et al.
Published: (2024-12-01)

Rhabdomyolysis secondary to COVID-19 infection and vaccination: a review of literature
by: Mehdi Karimi, et al.
Published: (2024-11-01)

Effectiveness of HPV vaccination in reducing infection among young Brazilian women
by: Ana Carolina da Silva Santos, et al.
Published: (2025-01-01)

African swine fever clinical scoring system
by: M. E. Vlasov, et al.
Published: (2024-12-01)

Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
by: Ashenafi Kibret Sendekie, et al.
Published: (2025-01-01)

Geospatial Variation in Vaccination Coverage and Zero-Dose Prevalence at the District, Ward and Health Facility Levels Before and After a Measles Vaccination Campaign in Nigeria
by: C. Edson Utazi, et al.
Published: (2024-11-01)

INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY
by: Giuseppe La Torre
Published: (2016-09-01)

An Outbreak of Measles in Iraq
by: Raid Al-Ani, et al.
Published: (2024-06-01)

The Costs and Cost-Effectiveness of a Two-Dose Oral Cholera Vaccination Campaign: A Case Study in a Refugee Camp Setting in Thailand
by: Aaron S. Wallace, et al.
Published: (2024-10-01)